
ADC Therapeutics SA: shareholders and insiders
Price
$1.37
November 18, 2026Market cap $174M
What Ploutos Investor adds for ADC Therapeutics SA
Part of Ploutos Investor, €9.99 a month
- The full history: 8 fiscal years, from 2018
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Insiders and their shares
Purchases and sales by officers and directors from Nov 19, 2025 to Jul 2, 2026, from their own Form 4 filings.
Insider trades start on February 9, 2024
Until lately ADC Therapeutics SA was a foreign company listed in the US. Officers of foreign companies do not report their purchases and sales, so there are none before. They are not missing on our side: they were never filed.
- Until 2023Foreign company (annual report on 20-F)
- March 2024Becomes a US filer (annual report on 10-K)
- February 9, 2024The first insider trade report (Form 4)
Bought on the market
–
nobody
Sold on the market
$20M
1 person
From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
- Jun 30, 2026Mohamed ZakiChief Medical OfficerKind
- Jun 30, 2026Peter J GrahamChief Legal OfficerKind
- Jun 30, 2026Jose CarmonaChief Financial OfficerKind
- Jun 30, 2026Ameet MallikChief Executive OfficerKind
- Jun 3, 2026Robert AzelbyDirectorKind
- Jun 3, 2026Ron SquarerDirectorKind
- Jun 3, 2026Victor SandorDirectorKind
- Jun 3, 2026Viviane MongesDirectorKind
- Jun 3, 2026Peter HugDirectorKind
- Jun 3, 2026Jean-pierre BizzariDirectorKind
- Jun 3, 2026Timothy CoughlinDirectorKind
- Jun 1, 2026Robert AzelbyDirectorKind
- Jun 1, 2026Ron SquarerDirectorKind
- Jun 1, 2026Victor SandorDirectorKind
- Jun 1, 2026Viviane MongesDirectorKind
- Jun 1, 2026Peter HugDirectorKind
- Jun 1, 2026Jean-pierre BizzariDirectorKind
- Jun 1, 2026Timothy CoughlinDirectorKind
- Apr 2, 2026RedCo II Master Fund, L.P.Kind
- Apr 2, 2026RedCo II Master Fund, L.P.Kind
- Apr 1, 2026RedCo II Master Fund, L.P.Kind
- Apr 1, 2026RedCo II Master Fund, L.P.Kind
- Mar 31, 2026RedCo II Master Fund, L.P.Kind
- Mar 31, 2026RedCo II Master Fund, L.P.Kind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Mohamed ZakiChief Medical Officer | 213.9K | – | – | Form 4 | |
| Jun 30, 2026 | Peter J GrahamChief Legal Officer | 221.1K | – | – | Form 4 | |
| Jun 30, 2026 | Jose CarmonaChief Financial Officer | 203.7K | – | – | Form 4 | |
| Jun 30, 2026 | Ameet MallikChief Executive Officer | 675.0K | – | – | Form 4 | |
| Jun 3, 2026 | Robert AzelbyDirector | 12.6K | $3.08 | $38.8K | Form 4 | |
| Jun 3, 2026 | Ron SquarerDirector | 15.2K | $3.08 | $46.8K | Form 4 | |
| Jun 3, 2026 | Victor SandorDirector | 12.6K | $3.08 | $38.8K | Form 4 | |
| Jun 3, 2026 | Viviane MongesDirector | 2,596 | $3.08 | $8.0K | Form 4 | |
| Jun 3, 2026 | Peter HugDirector | 2,156 | $3.08 | $6.6K | Form 4 | |
| Jun 3, 2026 | Jean-pierre BizzariDirector | 12.6K | $3.08 | $38.8K | Form 4 | |
| Jun 3, 2026 | Timothy CoughlinDirector | 12.6K | $3.08 | $38.8K | Form 4 | |
| Jun 1, 2026 | Robert AzelbyDirector | 45.0K | – | – | Form 4 | |
| Jun 1, 2026 | Ron SquarerDirector | 45.0K | – | – | Form 4 | |
| Jun 1, 2026 | Victor SandorDirector | 45.0K | – | – | Form 4 | |
| Jun 1, 2026 | Viviane MongesDirector | 45.0K | – | – | Form 4 | |
| Jun 1, 2026 | Peter HugDirector | 45.0K | – | – | Form 4 | |
| Jun 1, 2026 | Jean-pierre BizzariDirector | 45.0K | – | – | Form 4 | |
| Jun 1, 2026 | Timothy CoughlinDirector | 45.0K | – | – | Form 4 | |
| Apr 2, 2026 | RedCo II Master Fund, L.P. | 2.53M | $3.28 | $8.3M | Form 4 | |
| Apr 2, 2026 | RedCo II Master Fund, L.P. | 2.63M | $3.28 | $8.6M | Form 4 | |
| Apr 1, 2026 | RedCo II Master Fund, L.P. | 169.3K | $3.80 | $643.2K | Form 4 | |
| Apr 1, 2026 | RedCo II Master Fund, L.P. | 162.5K | $3.80 | $617.6K | Form 4 | |
| Mar 31, 2026 | RedCo II Master Fund, L.P. | 188.4K | $3.75 | $706.5K | Form 4 | |
| Mar 31, 2026 | RedCo II Master Fund, L.P. | 196.2K | $3.75 | $735.9K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 3, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by ADCT's officers and directors from 2024 up to November 18, 2025, 2 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Bain Capital Life Sciences Opportunities IV, L.P.Common Shares, par value CHF 0.08 per shareShare of class9.99%
- Redmile Group, LLCwith 3 more personsCommon Shares, par value CHF 0.08 per shareShare of class9.90%
- Nantahala Capital Management, LLCwith 2 more personsCommon Shares, par value CHF 0.08 per shareShare of class9.69%
- Hpwh Thwith 2 more personsCommon Shares, par value CHF 0.08 per shareShare of class9.61%
- TCG Crossover GP II, LLCwith 2 more personsCommon Shares, par value CHF $0.08 per shareShare of class9.20%
- Prosight Management, LPwith 4 more personsCommon SharesShare of class6.80%
- BlackRock, Inc.Share of class5.40%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Opportunities IV, L.P.Common Shares, par value CHF 0.08 per share | 9.99% | 14.83M | Oct 29, 2026 | 13G | |
| Redmile Group, LLCwith 3 more personsCommon Shares, par value CHF 0.08 per share | 9.90% | 12.72M | Apr 24, 20264 filings since Aug 14, 2025 | 13G/A | |
| Nantahala Capital Management, LLCwith 2 more personsCommon Shares, par value CHF 0.08 per share | 9.69% | 12.33M | Aug 14, 2026 | 13G | |
| Hpwh Thwith 2 more personsCommon Shares, par value CHF 0.08 per share | 9.61% | 9.79M | May 19, 2025 | 13G/A | |
| TCG Crossover GP II, LLCwith 2 more personsCommon Shares, par value CHF $0.08 per share | 9.20% | 11.39M | Feb 17, 2026 | 13G | |
| Prosight Management, LPwith 4 more personsCommon Shares | 6.80% | 8.48M | Feb 13, 20262 filings since Nov 13, 2025 | 13G/A | |
| BlackRock, Inc. | 5.40% | 6.86M | Jul 27, 20263 filings since Feb 3, 2025 | 13G |
Fell to 5% or less (3)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter-88%
- Citadel Advisors (Griffin)In the quarter+19%
- Millennium Mgmt (Englander)In the quarter
- D.E. ShawIn the quarter+111%
- Renaissance TechnologiesIn the quarter
- AQR CapitalIn the quarter+242%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | 447.8K | -88% | $500.0K | 0.00% |
| Citadel Advisors (Griffin) | 2.45M | +19% | $3.0M | 0.00% |
| Millennium Mgmt (Englander) | – | – | 0.00% | |
| D.E. Shaw | 1.51M | +111% | $1.8M | 0.00% |
| Renaissance Technologies | 384.8K | $500.0K | 0.00% | |
| AQR Capital | 2.25M | +242% | $2.7M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 4.99% of its shares outstanding were held short, -8.1% since the report before.
- Shares held short
- 6.34M
- 4.99%
- Since the report before6.90M on Sep 30, 2026
- -8.1%
- 2.9
- 2.16M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 34%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 3.97M
- Nov 15, 2023: Shares held short 3.62M
- Nov 30, 2023: Shares held short 4.09M
- Dec 15, 2023: Shares held short 4.05M
- Dec 29, 2023: Shares held short 3.72M
- Jan 12, 2024: Shares held short 3.36M
- Jan 31, 2024: Shares held short 2.93M
- Feb 15, 2024: Shares held short 1.43M
- Feb 29, 2024: Shares held short 868.8K
- Mar 15, 2024: Shares held short 939.7K
- Mar 28, 2024: Shares held short 993.1K
- Apr 15, 2024: Shares held short 888.1K
- Apr 30, 2024: Shares held short 857.6K
- May 15, 2024: Shares held short 1.00M
- May 31, 2024: Shares held short 982.5K
- Jun 14, 2024: Shares held short 822.4K
- Jun 28, 2024: Shares held short 819.5K
- Jul 15, 2024: Shares held short 3.19M
- Jul 31, 2024: Shares held short 3.00M
- Aug 15, 2024: Shares held short 2.97M
- Aug 30, 2024: Shares held short 2.71M
- Sep 13, 2024: Shares held short 3.14M
- Sep 30, 2024: Shares held short 3.56M
- Oct 15, 2024: Shares held short 3.51M
- Oct 31, 2024: Shares held short 3.17M
- Nov 15, 2024: Shares held short 3.16M
- Nov 29, 2024: Shares held short 3.01M
- Dec 13, 2024: Shares held short 4.12M
- Dec 31, 2024: Shares held short 4.86M
- Jan 15, 2025: Shares held short 5.18M
- Jan 31, 2025: Shares held short 4.86M
- Feb 14, 2025: Shares held short 4.87M
- Feb 28, 2025: Shares held short 5.30M
- Mar 14, 2025: Shares held short 4.56M
- Mar 31, 2025: Shares held short 4.29M
- Apr 15, 2025: Shares held short 4.53M
- Apr 30, 2025: Shares held short 4.47M
- May 15, 2025: Shares held short 4.33M
- May 30, 2025: Shares held short 4.27M
- Jun 13, 2025: Shares held short 4.53M
- Jun 30, 2025: Shares held short 4.91M
- Jul 15, 2025: Shares held short 5.46M
- Jul 31, 2025: Shares held short 5.68M
- Aug 15, 2025: Shares held short 4.51M
- Aug 29, 2025: Shares held short 4.14M
- Sep 15, 2025: Shares held short 4.07M
- Sep 30, 2025: Shares held short 5.30M
- Oct 15, 2025: Shares held short 6.37M
- Oct 31, 2025: Shares held short 6.48M
- Nov 14, 2025: Shares held short 5.87M
- Nov 28, 2025: Shares held short 6.03M
- Dec 15, 2025: Shares held short 6.77M
- Dec 31, 2025: Shares held short 3.57M
- Jan 15, 2026: Shares held short 3.83M
- Jan 30, 2026: Shares held short 4.42M
- Feb 13, 2026: Shares held short 4.36M
- Feb 27, 2026: Shares held short 4.11M
- Mar 13, 2026: Shares held short 4.29M
- Mar 31, 2026: Shares held short 4.90M
- Apr 15, 2026: Shares held short 5.14M
- Apr 30, 2026: Shares held short 5.47M
- May 15, 2026: Shares held short 5.75M
- May 29, 2026: Shares held short 6.07M
- Jun 15, 2026: Shares held short 6.00M
- Jun 30, 2026: Shares held short 5.99M
- Jul 15, 2026: Shares held short 5.53M
- Jul 31, 2026: Shares held short 5.09M
- Aug 14, 2026: Shares held short 6.18M
- Aug 31, 2026: Shares held short 6.29M
- Sep 15, 2026: Shares held short 5.39M
- Sep 30, 2026: Shares held short 6.90M
- Oct 15, 2026: Shares held short 6.34M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading46.4% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 46.4% of the shares in the reported trades were short sales, against 39.4% in the 14 before.
- Last 14 sessionsOct 30, 2026 – Nov 18, 2026
- 46.4%
- The 14 beforeOct 12, 2026 – Oct 29, 2026
- 39.4%
- Change
- +7.0 pts
- Short sales a dayon average, of 592.5K shares
- 275.2K
- More than atof 3,656 US-listed companies, same days
- 36%
- Median of alleight in ten from 34.4% to 63.7%
- 50.3%
- Short sales
- Oct 12, 2026: Short sales 26.9%
- Oct 13, 2026: Short sales 25.6%
- Oct 14, 2026: Short sales 46%
- Oct 15, 2026: Short sales 41.2%
- Oct 16, 2026: Short sales 58.8%
- Oct 19, 2026: Short sales 41.7%
- Oct 20, 2026: Short sales 55.9%
- Oct 21, 2026: Short sales 44.5%
- Oct 22, 2026: Short sales 45.5%
- Oct 23, 2026: Short sales 49.7%
- Oct 26, 2026: Short sales 55.1%
- Oct 27, 2026: Short sales 56.6%
- Oct 28, 2026: Short sales 35.5%
- Oct 29, 2026: Short sales 17.8%
- Oct 30, 2026: Short sales 30.1%
- Nov 2, 2026: Short sales 34.5%
- Nov 3, 2026: Short sales 40.6%
- Nov 4, 2026: Short sales 31.4%
- Nov 5, 2026: Short sales 70.5%
- Nov 6, 2026: Short sales 42.2%
- Nov 9, 2026: Short sales 63.9%
- Nov 10, 2026: Short sales 18.1%
- Nov 11, 2026: Short sales 52.9%
- Nov 12, 2026: Short sales 70.1%
- Nov 13, 2026: Short sales 44.9%
- Nov 16, 2026: Short sales 50.1%
- Nov 17, 2026: Short sales 43.6%
- Nov 18, 2026: Short sales 43.1%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Jeremy GreenTenPercentOwnerDirectly13.15M
- RedCo II Master Fund, L.P.TenPercentOwnerDirectly10.27M
- Ameet MallikChief Executive OfficerDirectly2.12M
- Jose CarmonaChief Financial OfficerDirectly938.1K
- Mohamed ZakiChief Medical OfficerDirectly896.3K
- Peter J GrahamChief Legal OfficerDirectly841.6K
- Peter HugDirectorDirectly263.3K
- Thomas PfistererDirectorDirectly213.9K
- Viviane MongesDirectorDirectly186.4K
- Victor SandorDirectorDirectly140.7K
- Jean-pierre BizzariDirectorDirectly139.3K
- Ron SquarerDirectorDirectly123.4K
- Robert AzelbyDirectorDirectly112.8K
- Timothy CoughlinDirectorDirectly72.4K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Jeremy GreenTenPercentOwner | 13.15M | 15.67M | Dec 11, 2024 | Form 4 |
| RedCo II Master Fund, L.P.TenPercentOwner | 10.27M | 12.67M | Apr 2, 2026 | Form 4 |
| Ameet MallikChief Executive Officer | 2.12M | – | Jun 30, 2026 | Form 4 |
| Jose CarmonaChief Financial Officer | 938.1K | – | Jun 30, 2026 | Form 4 |
| Mohamed ZakiChief Medical Officer | 896.3K | – | Jun 30, 2026 | Form 4 |
| Peter J GrahamChief Legal Officer | 841.6K | – | Jun 30, 2026 | Form 4 |
| Peter HugDirector | 263.3K | – | Jun 3, 2026 | Form 4 |
| Thomas PfistererDirector | 213.9K | – | Jun 17, 2024 | Form 4 |
| Viviane MongesDirector | 186.4K | – | Jun 3, 2026 | Form 4 |
| Victor SandorDirector | 140.7K | – | Jun 3, 2026 | Form 4 |
| Jean-pierre BizzariDirector | 139.3K | – | Jun 3, 2026 | Form 4 |
| Ron SquarerDirector | 123.4K | – | Jun 3, 2026 | Form 4 |
| Robert AzelbyDirector | 112.8K | – | Jun 3, 2026 | Form 4 |
| Timothy CoughlinDirector | 72.4K | – | Jun 3, 2026 | Form 4 |
A lower bound: it counts only the 14 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.03%
- IBBiShares Biotechnology ETFWeight in the fund0.01%
- IWNiShares Russell 2000 Value ETFWeight in the fund0.01%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.00%
- IWMiShares Russell 2000 ETFWeight in the fund0.00%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.00%
- IWViShares Russell 3000 ETFWeight in the fund0.00%
7 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 106
- Q4 2025: Managers 115
- Q1 2026: Managers 119
- Q2 2026: Managers 114
Institutional investors by quarter
The fund managers holding ADCT, quarter by quarter, from Q2 2020 to Q2 2025, 21 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 114 managers held 93.07M shares, worth $100M. During the quarter 27 opened a position, 31 closed one, 42 added and 29 trimmed.
The largest holders, Q2 2026
- Nantahala Capital ManagementIn the quarter+340%
- Redmile GroupIn the quarter-25%
- TCG Crossover ManagementIn the quarter
- Prosight ManagementIn the quarter-5.7%
- BlackRockIn the quarter+12%
- Point72 (Cohen)In the quarter+7.9%
- Morgan StanleyIn the quarter-20%
- Millennium Mgmt (Englander)In the quarter-7.0%
- Citadel Advisors (Griffin)In the quarter+414%
- Goldman Sachs GroupIn the quarter+16%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Nantahala Capital Management | 24.65M | +340% | $26M |
| Redmile Group | 11.53M | -25% | $12M |
| TCG Crossover Management | 11.39M | $12M | |
| Prosight Management | 7.82M | -5.7% | $8.4M |
| BlackRock | 7.02M | +12% | $7.5M |
| Point72 (Cohen) | 3.65M | +7.9% | $3.9M |
| Morgan Stanley | 3.05M | -20% | $3.3M |
| Millennium Mgmt (Englander) | 2.90M | -7.0% | $3.1M |
| Citadel Advisors (Griffin) | 2.05M | +414% | $2.2M |
| Goldman Sachs Group | 1.91M | +16% | $2.0M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do ADC Therapeutics SA's filings show?
Who buys and sells is one part of ADC Therapeutics SA's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have ADCT's insiders bought or sold?
From Jun 3, 2026 to Jul 2, 2026 ADC Therapeutics SA's insiders reported no purchase or sale of shares on the market.
Which well-known managers hold ADCT?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $3.0M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.